Related Experiment Video

Updated: Jun 7, 2026

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

CSF α-synuclein as a diagnostic biomarker for Parkinson disease and related dementias

Clive G Ballard, Emma L Jones

    Neurology
    |October 22, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
    09:27

    Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

    Published on: January 5, 2016

    Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
    08:33

    Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

    Published on: June 25, 2019

    Related Experiment Videos

    Last Updated: Jun 7, 2026

    Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
    12:01

    Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

    Published on: May 30, 2015

    Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
    09:27

    Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

    Published on: January 5, 2016

    Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
    08:33

    Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

    Published on: June 25, 2019

    Related Concept Videos

    Parkinson Disease ll: Pathophysiology01:24

    Parkinson Disease ll: Pathophysiology

    Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
    Neural Regulation01:37

    Neural Regulation

    Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

    Articles linked to this work by shared authors, journal, and citation graph.

    The Relationship Between Polygenic Risk of Depression and Regional Brain Atrophy in Older Adults.

    International journal of geriatric psychiatry·2026

    Clinical Manifestations.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

    Clinical Manifestations.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

    Clinical Manifestations.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

    Clinical Manifestations.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

    Clinical Manifestations.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

    Quantitative Relationship Between Lumipulse G Measures of pTau217 in Plasma and the Temporal Cortex.

    Neurology·2026

    Dual Antiglutamate Therapy in Super-Refractory Status Epilepticus After Cardiac Arrest (SUPER-CAT Study).

    Neurology·2026

    What Is the Role of the Locus Coeruleus in Sleep, Cerebrovascular Control, and Glymphatic Clearance?

    Neurology·2026

    Ofatumumab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Nationwide Cohort Study.

    Neurology·2026

    Medium-Term Cognitive Outcome in Patients With CNS Lymphomas Treated With Chimeric Antigen Receptor T-Cell Therapy.

    Neurology·2026

    Association of Skin Denervation With Brain Atrophy and Cognitive Impairment in Patients With Parkinson Disease.

    Neurology·2026

    Cognitive impairment after cerebral ischemia-reperfusion injury: a neuroecosystem perspective.

    Frontiers in neurology·2026

    Cystatin F as a neuroimmune effector in CNS inflammation and neurodegeneration.

    Frontiers in cell and developmental biology·2026

    Non-invasive assessment of hepatic steatosis in Wilson Disease: An international registry-based study.

    Clinics and research in hepatology and gastroenterology·2026

    Probiotics Attenuate AlCl₃-Induced Alzheimer's Disease via Gut-Brain Axis Modulation and Suppression of NF-κB/NLRP3 Neuroinflammation.

    Physiology & behavior·2026

    Clusterin is enriched in plaque-associated astrocytes and localizes to synapses in Alzheimer's disease.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

    Intraosseous access in neurological emergencies: a critical narrative review and research framework.

    Future science OA·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us